Swissmedic approves Novartis’ malaria medicine for babies
The Swiss Agency for Therapeutic Products (Swissmedic) has approved Novartis’ Coartem (artemether-lumefantrine) Baby, described as the first malaria medicine for…
All articles by Srivani Venna
Srivani Venna
-
-
GSK acquires efimosfermin alfa from Boston Pharma for $2bn
GSK has concluded the acquisition of efimosfermin alfa, an investigational therapeutic for serious liver disease (SLD), from Boston Pharmaceuticals in…
-
Torrent Pharmaceuticals to acquire stake in JB Pharma for $3bn
Torrent Pharmaceuticals, headquartered in Gujerat, India, has signed definitive agreements for the acquisition of a controlling stake in JB Chemicals…
-
Sanofi begins shipping BEYFORTUS to US for RSV prevention in infants
French multinational pharmaceutical company Sanofi has commenced the shipping of BEYFORTUS (nirsevimab-alip) to the US, targeting both private healthcare providers…
-
SBTi approves Piramal Pharma’s GHG reduction targets
The Science Based Targets initiative (SBTi) has validated and approved India's Piramal Pharma’s near-term greenhouse gas (GHG) emission reduction targets.…
-
Regeneron’s Dupixent approved as first adolescent CRSwNP treatment
The US Food and Drug Administration (FDA) has expanded the approval of Dupixent (dupilumab) to include adolescents aged 12 to…
-
Lilly’s EBGLYSS gains FDA approval for patients aged 12 and older
Eli Lilly and Company has announced FDA approval of EBGLYSS (lebrikizumab-lbkz) to treat moderate-to-severe atopic dermatitis in adults and children…
-
SII and Oxford University’s malaria vax launched in Côte d’Ivoire
The R21/Matrix-M malaria vaccine, co-developed by the Serum Institute of India (SII) and the University of Oxford, has been launched…
-
AusperBio secures funding to advance AHB-137 for CHB
AusperBio has raised $37m in a Series A financing round to propel the clinical development of AHB-1 for chronic hepatitis…
-
Sanofi and Biovac partner to produce polio vaccines in Africa
Sanofi and Biovac have announced a partnership to establish the first African-based manufacturing capabilities for inactivated polio vaccines (IPV), marking…